Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

March 22-23, 2013

San Francisco, California

Continuing Medical Education

Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex®, LLC designates this live educational activity for a maximum 11.0 of AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Who Should Attend

This educational activity is designed for gastroenterologists, hospitalists, internists, physician assistants, nurses, surgeons, and other clinicians with an interest in treating patients with IBD inclusive of children, teens, and young adults.


Upon completion of this educational activity, participants should be able to:

  • Describe and implement the current standards of practice in IBD management
  • Formulate strategies for the optimal care of pediatric patients with IBD based on the evolution of patient management and treatment strategies
  • Evaluate the current evidence on risk stratification of pediatric patients to help guide therapy
  • Summarize the role of vaccinations, bone monitoring, and cancer screening for healthcare maintenance of IBD
  • Describe the benefits of using mucosal healing as a standard therapeutic endpoint
  • Explain the role of new imaging modalities in the evaluation and the appropriate treatment of patients with IBD
  • Employ best practices in the management of pregnant women with IBD undergoing biologic treatment regimens
  • Implement into practice the use of novel assays that monitor drug levels and antibodies-to-drugs in maximizing therapeutic response in IBD